BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11190653)

  • 1. Artificial hepatic support. Where are we now?
    Davenport A
    Blood Purif; 2001; 19(1):1-3. PubMed ID: 11190653
    [No Abstract]   [Full Text] [Related]  

  • 2. [Liver failure].
    Yoshiba M
    Nihon Rinsho; 2004 May; 62 Suppl 5():545-9. PubMed ID: 15197981
    [No Abstract]   [Full Text] [Related]  

  • 3. [Apheresis treatment for fulminant hepatitis].
    Tateishi Y; Hirasawa H; Nitta M
    Nihon Rinsho; 2004 May; 62 Suppl 5():462-6. PubMed ID: 15197964
    [No Abstract]   [Full Text] [Related]  

  • 4. [Analysis of the prognosis of severe hepatitis treated with molecular adsorbent recycling system (MARS) using MELD score].
    Sun LH; Zhang YX; Xiao L; Lu XB
    Zhonghua Gan Zang Bing Za Zhi; 2005 Aug; 13(8):632, 635. PubMed ID: 16093004
    [No Abstract]   [Full Text] [Related]  

  • 5. Support for the acutely failing liver: a comprehensive review of historic and contemporary strategies.
    Barshes NR; Gay AN; Williams B; Patel AJ; Awad SS
    J Am Coll Surg; 2005 Sep; 201(3):458-76. PubMed ID: 16125082
    [No Abstract]   [Full Text] [Related]  

  • 6. Prometheus: from legend to the real liver support therapy.
    Rifai K; Tetta C; Ronco C
    Int J Artif Organs; 2007 Oct; 30(10):858-63. PubMed ID: 17992646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A report from the Second China National Annual Meeting of Artificial Liver and Blood Purification].
    Chen Y; Duan ZP
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):949-50. PubMed ID: 16381652
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of immunoadsorbent devices for maintaining hepatic function in ex vivo direct xenogenic hemoperfusion.
    Shindoh J; Naruse K; Sakai Y; Makuuchi M
    Int J Artif Organs; 2004 Apr; 27(4):294-302. PubMed ID: 15163063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal liver support.
    Stange J
    Organogenesis; 2011; 7(1):64-73. PubMed ID: 21343699
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of a multifunctional detoxifying unit for liver failure patients.
    Lee K; Mun CH; Min BG
    Blood Purif; 2012; 34(3-4):225-30. PubMed ID: 23171622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of liver support systems.
    Kaptanoglu L; Blei AT
    Clin Liver Dis; 2000 Aug; 4(3):711-29, x. PubMed ID: 11232169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Hemoadsorption in a Case of Severe Hepatic Failure and Hyperbilirubinemia.
    Faltlhauser A; Kullmann F
    Blood Purif; 2017; 44(2):98-99. PubMed ID: 28355595
    [No Abstract]   [Full Text] [Related]  

  • 13. Artificial liver support at present and in the future.
    Onodera K; Sakata H; Yonekawa M; Kawamura A
    J Artif Organs; 2006; 9(1):17-28. PubMed ID: 16614798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure.
    Di Campli C; Santoro MC; Gaspari R; Merra G; Zileri Dal Verme L; Zocco MA; Piscaglia AC; Di Gioacchino G; Novi M; Santoliquido A; Flore R; Tondi P; Proietti R; Gasbarrini G; Pola P; Gasbarrini A
    Transplant Proc; 2005; 37(6):2547-50. PubMed ID: 16182739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The enhancement of treatment efficacy in chronic liver failure by using hemoperfusion across donor hepatocytes and spleen fragments].
    Onishchenko NA; Bazieva FKh; Orzhekhovskaia IG; Toshchakov VIu; Polosina OV; Danilov MA; Suskova VS
    Ter Arkh; 1995; 67(2):6-9. PubMed ID: 7725264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Model selection and curative effect judgment criteria for artificial liver in the treatment of liver failure].
    Zhou L; Chen Y
    Zhonghua Gan Zang Bing Za Zhi; 2022 Feb; 30(2):127-130. PubMed ID: 35359063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of molecular adsorbent recirculating system for the treatment of intractable pruritus in cholestasis.
    Macia M; Avilés J; Navarro J; Morales S; García J
    Am J Med; 2003 Jan; 114(1):62-4. PubMed ID: 12543292
    [No Abstract]   [Full Text] [Related]  

  • 18. Artificial liver support system in China: a review over the last 30 years.
    Li LJ; Zhang YM; Liu XL; Du WB; Huang JR; Yang Q; Xu XW; Chen YM
    Ther Apher Dial; 2006 Apr; 10(2):160-7. PubMed ID: 16684218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of artificial liver support system on the hepatic functional reserve in patients with liver failure].
    Zhou J; Ye JM; Wang XL; Chen H; Xu MF; Huang JR
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):311-2. PubMed ID: 21805742
    [No Abstract]   [Full Text] [Related]  

  • 20. Extracorporeal artificial liver support in hepatic failure: pathfinder, bridge to recovery or dead end street?
    Fuhrmann V; Derfler K; Trauner M
    Liver Int; 2011 Sep; 31 Suppl 3():iv. PubMed ID: 21824273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.